DLCI-1 is a potent and selective oral inhibitor of cytochrome P450 2A6 (CYP2A6) that markedly reduces nicotine self-administration in both male and female mice.
Molecular Weight:
218.32
CAS Number:
[2244569-14-8]
Formula:
C12H14N2S
Target:
Cytochrome P450
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted